Skip to main content
. 2020 Jul 28;1(2):104–110. doi: 10.1016/j.jdin.2020.05.006

Table III.

Perceived risks among product users and nonusers

Users,
No. (%)
Nonusers,
No. (%)
No risks 37 (27.6) 14 (7.1)
Lightening of skin 38 (28.4) 84 (42.6)
Darkening of skin 61 (45.5) 98 (49.7)
Increased skin infections 25 (18.7) 72 (36.5)
Skin redness 26 (19.4) 64 (32.5)
Thinning of skin 28 (20.9) 60 (30.5)
Increased stretch marks 37 (27.6) 79 (40.1)
More sensitive skin 16 (11.9) 50 (25.4)
Fishy body odor 21 (15.7) 71 (36.0)
Skin cancer 5 (3.7) 12 (6.1)